U.S. flag

An official website of the United States government

NM_024537.4(CARS2):c.84G>T (p.Trp28Cys) AND Combined oxidative phosphorylation defect type 27

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001297257.3

Allele description [Variation Report for NM_024537.4(CARS2):c.84G>T (p.Trp28Cys)]

NM_024537.4(CARS2):c.84G>T (p.Trp28Cys)

Genes:
LOC130010127:ATAC-STARR-seq lymphoblastoid silent region 5509 [Gene]
CARS2:cysteinyl-tRNA synthetase 2, mitochondrial [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q34
Genomic location:
Preferred name:
NM_024537.4(CARS2):c.84G>T (p.Trp28Cys)
HGVS:
  • NC_000013.11:g.110706010C>A
  • NG_042045.2:g.12592G>T
  • NM_001352252.2:c.-776+361G>T
  • NM_001352253.3:c.84G>T
  • NM_024537.2:c.84G>T
  • NM_024537.4:c.84G>TMANE SELECT
  • NP_001339182.1:p.Trp28Cys
  • NP_078813.1:p.Trp28Cys
  • NC_000013.10:g.111358357C>A
  • NG_042045.1:g.5171G>T
  • NR_147942.2:n.107G>T
Protein change:
W28C
Links:
dbSNP: rs1388391654
NCBI 1000 Genomes Browser:
rs1388391654
Molecular consequence:
  • NM_001352252.2:c.-776+361G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001352253.3:c.84G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024537.4:c.84G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147942.2:n.107G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Combined oxidative phosphorylation defect type 27
Synonyms:
Combined oxidative phosphorylation deficiency 27
Identifiers:
MONDO: MONDO:0014728; MedGen: C5567608; OMIM: 616672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001486264Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 5, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001486264.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 28 of the CARS2 protein (p.Trp28Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1001034). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 14, 2023